Biotech & pharma
Modified bacteria could be used in vaccines
By By Sam Wong | 18 Apr 2013
After Dolly, Roslin researchers create GM-modified piglet
17 Apr 2013
The male piglet, Pig 26, was born last August, and had been genetically engineered with the smallest of DNA mutations - a single deletion of one out of the 3 billion chemical "letters" of its entire genome
Patterning graphene with DNA
By Anne Trafton, MIT News Office | 10 Apr 2013
Folded DNA templates allow researchers to precisely cut out graphene shapes, which could be used in electronic circuits.
'Sonic lasso' catches cells
10 Apr 2013
Academics have demonstrated for the first time that a “sonic lasso” can be used to grip microscopic objects, such as cells, and move them about.
Cancer biologists find DNA-damaging toxins in common plant-based foods
06 Apr 2013
Liquid smoke, black and green teas and coffee produced levels of cell DNA damage comparable to chemo drugs
Study offers new way to discover HIV vaccine targets
By By Anne Trafton, MIT News Office | 23 Mar 2013
Researchers spot molecular control switch for preterm lung disorders
By By Karen N. Peart | 22 Mar 2013
Researchers create tomatoes that mimic actions of good cholesterol
By By Rachel Champeau | 22 Mar 2013
Breaking down the Parkinson’s pathway
By By Anne Trafton, MIT News Office | 18 Mar 2013
Study finds white blood cells control red blood cell levels
18 Mar 2013
The findings could lead to novel therapies for diseases or conditions in which the red blood cell production is thrown out of balance
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
